Yangxun Pan
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Cancer, Lipids, and Metabolism
Papers in
- Hepatology 37
- Hepatocellular Carcinoma Treatment and Prognosis 37
-
- Cancer, Lipids, and Metabolism 10
Yangxun Pan
55 papers receiving 487 citations
Peers
Comparison fields: 5 of 61
- Hepatology 243
- Cancer Research 114
- Oncology 161
- Epidemiology 119
- Surgery 149
Countries citing papers authored by Yangxun Pan
This map shows the geographic impact of Yangxun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangxun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangxun Pan more than expected).
Fields of papers citing papers by Yangxun Pan
This network shows the impact of papers produced by Yangxun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangxun Pan. The network helps show where Yangxun Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangxun Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 17 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 20 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2020 | 12 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 16 | |
| 20 | 2019 | 1 |
About Yangxun Pan
Yangxun Pan is a scholar working on Hepatology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 492 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Liver Disease Diagnosis and Treatment (10 papers), Cancer, Lipids, and Metabolism (10 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers), Cancer Mechanisms and Therapy (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Hepatology (243 citations), Cancer Research (114 citations), Oncology (161 citations), Epidemiology (119 citations) and Surgery (149 citations). Yangxun Pan has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Yaojun Zhang, Minshan Chen, Jinbin Chen, Li Xu, Zhongguo Zhou, Juncheng Wang, Dandan Hu, Yizhen Fu, Zili Hu and Jiancong Chen. Their work appears in journals such as International Journal of Surgery, Frontiers in Oncology, Journal of Cancer Research and Clinical Oncology, Frontiers in Pharmacology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.